0     

Rojas JI, Gracia F, Parciak T, Alonso R, Becker J, Trevino-Frenk I, et al. [Core data set for real world data in multiple sclerosis: Customization for Latin America from a global task force recommendation]. Rev Neurol. 2024;78(7):185-97. PMID: 38502167.

0     

Román MS, González FM, Bardoneschi L, Herrera Fernández M, Eizaguirre MB, Cáceres F, et al. Contextual factors matter: The role of social support in work-related difficulties and employment status in persons with multiple sclerosis. Sclerosis. 2024;2(1):65-76. DOI: 10.3390/sclerosis2010005.

0     

Avila M, Tan Y, Hernandez R, Zuberi H, Rivera VM. Correction to: Multiple aclerosis and neuromyelitis optica spectrum disorder: Onset following acute COVID-19 infection, a case series. Neurol Ther. 2023;12(2):701. PMID: 36821074.

0     

Avila M, Tan Y, Hernandez R, Zuberi H, Rivera VM. Multiple Sclerosis and neuromyelitis optica spectrum disorder: Onset following acute COVID-19 infection, a case series. Neurol Ther. 2023;12(1):319-27. PMID: 36399224.

0     

Rivera VM. Neuromyelitis optica spectrum disorder: Redefining an old disease. Present and future challenges. J Integr Neurosci. 2023;22(6):139. PMID: 38176944.

0     

Gracia F, Ramírez D, Parajeles-Vindas A, Díaz A, Díaz de la Fé A, Sánchez NER, et al. Neuromyelitis optica spectrum disorder in Central America and the Caribbean: A multinational clinical characterization study. Neurol Int. 2022;14(1):284-93. DOI: 10.3390/neurolint14010023.

0     

Amezcua L, Rivera VM, Vazquez TC, Baezconde-Garbanati L, Langer-Gould A. Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: A review. JAMA Neurol. 2021;78(12):1515-24. PMID: 34605866.

0     

Cristiano E, Abad P, Becker J, Carra A, Correale J, Flores J, et al. Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation. J Neurol Sci. 2021;429:118072. PMID: 34509134.

0     

Rivera VM, Hamuy F, Rivas V, Gracia F, Rojas JI, Bichuetti DB, et al. Status of the neuromyelitis optica spectrum disorder in Latin America. Mult Scler Relat Disord. 2021;53:103083. DOI: https://doi.org/10.1016/j.msard.2021.103083.

0     

Rivera VM. Editorial of special issue "Multiple sclerosis: Diagnosis and treatment II". Biomedicines. 2021;9(11):. PMID: 34829833.

0     

Rojas JI, Carnero Contentti E, Abad P, Aguayo A, Alonso R, Bauer J, et al. Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAM. Mult Scler Relat Disord. 2021;53:103038. PMID: 34090128.

0     

Fisher KS, Cuascut FX, Rivera VM, Hutton GJ. Current advances in pediatric onset multiple sclerosis. Biomedicines. 2020;8(4):. PMID: 32231060.

0     

Rivera VM, Gracia F, Diaz A. Therapeutic attitudes towards multiple sclerosis in Central America and the Caribbean facing the SARS-CoV-2 pandemia. Neurologia. 2020;35(9):705-6. PMID: 32893070.

1

Rivera VM. Biosimilar drugs for multiple sclerosis: An unmet international need or a regulatory risk? Neurol Ther. 2019;8(2):177-84. PMID: 31313222.

0     

Rivera VM. Multiple sclerosis as a universal disease and the challenges to immigrants in high prevalence countries. Eur J Neurol. 2018;25(4):612-3. PMID: 29341368.

3

Rivera VM. Multiple sclerosis: a global concern with multiple challenges in an era of advanced therapeutic complex molecules and biological medicines. Biomedicines. 2018;6(4):. PMID: 30513578.

0     

Rivera VM. Multiple sclerosis: depression and disability are globally shared issues of concern. Neurol Neuroimmunol Neuroinflamm. 2018;5(4):12. DOI: 10.20517/2347-8659.2018.16.

0     

Rivera VM, Macias MA. Access and barriers to MS care in Latin America. Mult Scler J Exp Transl Clin. 2017;3(1):2055217317700668. DOI: doi:10.1177/2055217317700668.

0     

Rivera VM. Medicinal cannabis: Cultural, societal and regulatory challenges in the Americas. Ann Forensic Res Anal. 2017;4(1):1038.

7

Rivera VM. Multiple Sclerosis in Latin Americans: Genetic Aspects. Curr Neurol Neurosci Rep. 2017;17(8):57. PMID: 28639238.

0     

Rivera-Olmos VM, Parra-Bernal MC. [Cannabis: Effects in the central nervous system. Therapeutic, societal and legal consequences]. Rev Med Inst Mex Seguro Soc. 2016;54(5):626-34. PMID: 27428345.

11

Rivera VM, Medina MT, Duron RM, Macias MA. Multiple sclerosis care in Latin America. Neurology. 2014;82(18):1660-1. PMID: 24799516.

4

Macias-Islas MA, Soria-Cedillo IF, Velazquez-Quintana M, Rivera VM, Baca-Muro VI, Lemus-Carmona EA, et al. Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis. Acta Neurol Belg. 2013;113(4):415-20. PMID: 23670405.

25

Rivera VM, Jeffery DR, Weinstock-Guttman B, Bock D, Dangond F. Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study. BMC Neurol. 2013;13:80. PMID: 23841877.

6

Abad P, Nogales-Gaete J, Rivera V, Cristiano E, Hamuy F, Oehninger C, et al. [LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants]. Rev Neurol. 2012;55(12):737-48. PMID: 23233142.

0     

Avila-Ornelas J, Avila M, Stosic M, Robles L, Prieto PG, Hutton GJ, et al. The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis. Int J MS Care. 2011;13(2):91-3. PMID: 24453710.

4

Rivera VM. Tovaxin for multiple sclerosis. Expert Opin Biol Ther. 2011;11(7):961-7. PMID: 21563876.

11

Stosic M, De Jesus P, McCarthy J, Hutton G, Rivera V. Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab. Neurology. 2011;77(5):505-7. PMID: 21775738.

35

Uitdehaag B, Constantinescu C, Cornelisse P, Jeffery D, Kappos L, Li D, et al. Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study. Ther Adv Neurol Disord. 2011;4(1):3-14. PMID: 21339904.

19

Cohen BA, Rivera VM. PRISMS: The story of a pivotal clinical trial series in multiple sclerosis. Curr Med Res Opin. 2010;26(4):827-38. PMID: 20121658.

1

Rivera VM. The challenge of follow-on biologics for treatment of multiple sclerosis. Neurology. 2010;74(10):864. PMID: 20211915.

10

Rivera VM. Multiple sclerosis in Latin America: Reality and challenge. Neuroepidemiology. 2009;32(4):294-5. PMID: 19246934.

0     

Cristiano E, Arcega R, Correale J, Gabbay AA, Lander-Delgado R, Macias-Islas MA, et al. [Recommendations for optimising the treatment of multiple sclerosis in Latin America]. Rev Neurol. 2007;44(8):494-8. PMID: 17455164.

9

Ordonez L, Skromne E, Ontaneda D, Rivera VM. Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndrome. Clin Neurol Neurosurg. 2007;109(1):102-5. PMID: 16624483.

0     

Rivera-Olmos VM, Avila MC. [Multiple sclerosis in Latin America. Are McDonald's criteria really applicable?]. Rev Mex Neuroci. 2007;8(1):49-56.

0     

Suarez GA, Hutton GJ, Rivera VM. Optic neuritis: Relation with multiple sclerosis. Acta Neurol Colomb. 2007;23:141-6.

0     

Suarez GA, Lotze TE, Hutton GJ, Rivera VM. Multiple sclerosis in the pediatric population. Acta Neurol Colomb. 2007;23:134-40.

87

Butzkueven H, Chapman J, Cristiano E, Grand'Maison F, Hoffmann M, Izquierdo G, et al. MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis. Mult Scler. 2006;12(6):769-74. PMID: 17263005.

0     

Carra A, Rivera-Olmos V, Arcega R, Gabbai A, Haussen SR, Luetic G, et al. [The treatment of multiple sclerosis in Latin America: Current practice and optimal standards. The findings of a survey among neurologists at an interactive workshop]. Rev Neurol. 2006;42(7):399-407. PMID: 16602056.

1

Skromne E, Rivera VM, Ontaneda D, Ordonez L. Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon. Neurology. 2006;66(11):1787-8; author reply 1787-8. PMID: 16769975.

2

Rivera VM. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 2005;64(12):2163. PMID: 15985607.

9

Rivera VM. Modafinil for the treatment of diminished responsiveness in a patient recovering from brain surgery. Brain Inj. 2005;19(9):725-7. PMID: 16195186.

1

Rivera VM. The terms Latino and Anglo and tendency to early Alzheimer disease. Arch Neurol. 2005;62(11):1787; author reply 1787-8. PMID: 16286562.

0     

Rivera-Olmos VM, Lozano JA. [Cogan's syndrome: Neurological manifestations. Case report and review of literature]. Rev Mex Neuroci. 2005;6(1):97-101.

50

Cohen BA, Khan O, Jeffery DR, Bashir K, Rizvi SA, Fox EJ, et al. Identifying and treating patients with suboptimal responses. Neurology. 2004;63(12 Suppl 6):S33-40. PMID: 15623669.

58

Hong J, Zang YC, Hutton G, Rivera VM, Zhang JZ. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis. J Neuroimmunol. 2004;152(1-2):126-39. PMID: 15223245.

15

Hong J, Zang YC, Li S, Rivera VM, Zhang JZ. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes. Eur J Immunol. 2004;34(3):870-81. PMID: 14991617.

0     

Rivera VM. Esclerosis multiple: evidencias, genericos y similares. Rev Mex Neuroci. 2004;5(4):286-7.

0     

Rivera-Olmos VM, Hutton GJ, Breitbach WT. Discrepancia entre clinica e imagen: Esclerosis multiple en fase intermedia. Presentacion de un caso y revision del tema [Discrepancy between clinics and image techniques: Intermediate phase of multiple sclerosis. A case report and review of the literature]. Rev Mex Neuroci. 2004;5(2):158-62.

98

Zang YC, Li S, Rivera VM, Hong J, Robinson RR, Breitbach WT, et al. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J Immunol. 2004;172(8):5120-7. PMID: 15067096.

22

Zang YC, Skinner SM, Robinson RR, Li S, Rivera VM, Hutton GJ, et al. Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis. Mult Scler. 2004;10(5):499-506. PMID: 15471364.

161

Frohman EM, Goodin DS, Calabresi PA, Corboy JR, Coyle PK, Filippi M, et al. The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003;61(5):602-11. PMID: 12963748.

38

Frohman TC, Frohman EM, O'Suilleabhain P, Salter A, Dewey RB, Jr, et al. Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography. Neurology. 2003;61(6):848-50. PMID: 14504338.

0     

Rivera VM. [Deciding on treatment in multiple sclerosis]. Rev Neurol. 2003;36(1):80-5. PMID: 12577220.

149

Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol. 2003;53(2):189-97. PMID: 12557285.

0     

Velazquez-Quintana M, Macias-Islas MA, Rivera-Olmos V, Lozano-Zarate J. [Multiple sclerosis in Mexico: A multicentre study]. Rev Neurol. 2003;36(11):1019-22. PMID: 12808495.

28

Zang Y, Hong J, Robinson R, Li S, Rivera VM, Zhang JZ. Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis. J Neuroimmunol. 2003;137(1-2):144-53. PMID: 12667659.

21

Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells. Int Immunol. 2003;15(9):1073-80. PMID: 12917259.

33

Hong J, Tejada-Simon MV, Rivera VM, Zang YC, Zhang JZ. Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult Scler. 2002;8(3):237-42. PMID: 12120696.

0     

Rivera VM. II Congreso de LACTRIMS. Rev Neurol. 2002;35(12):1175-6.

9

Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ. Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis. Immunology. 2002;107(4):403-10. PMID: 12460184.

52

Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Killian JM, Zhang JZ. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol. 2002;76(12):6147-54. PMID: 12021348.

64

Zang YC, Halder JB, Hong J, Rivera VM, Zhang JZ. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J Neuroimmunol. 2002;124(1-2):106-14. PMID: 11958828.

49

Zhang JZ, Rivera VM, Tejada-Simon MV, Yang D, Hong J, Li S, et al. T cell vaccination in multiple sclerosis: Results of a preliminary study. J Neurol. 2002;249(2):212-8. PMID: 11985389.

73

Ciancio SJ, Mutchnik SE, Rivera VM, Boone TB. Urodynamic pattern changes in multiple sclerosis. Urology. 2001;57(2):239-45. PMID: 11182328.

7

Rivera VM, Cabrera JA. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology. 2001;57(5):937-8. PMID: 11552042.

0     

Rivera VM. [Neuroimaging in multiple sclerosis]. Rev Neurol. 2001;32(3):283-5. PMID: 11310287.

3

Rivera VM. [Pharmacologic treatment of multiple sclerosis]. Rev Neurol. 2001;32(3):285-8. PMID: 11310288.

0     

Rivera VM. La decada del cerebro. Neurociencia. 2001;2(13):131.

41

Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol. 2001;31(3):907-17. PMID: 11241296.

82

Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol. 2001;112(1-2):174-80. PMID: 11108946.

35

Hong J, Zang YC, Tejada-Simon MV, Li S, Rivera VM, Killian J, et al. Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination. J Immunol. 2000;165(12):6858-64. PMID: 11120809.

0     

Rivera VM, Cabrera JA. La Esclerosis Multiple en Latino America. MEDICO Interamericano. 2000;19(10):458-65.

1

Rivera VM. [The treatment of multiple sclerosis with beta-interferon 1a]. Rev Neurol. 2000;31(5):470-1. PMID: 11027100.

0     

Rivera VM. Grupo de Estudio de EM (Mexico): Uso de Agentes Modificadores de la Enfermedad. Neurociencia. 2000;3:29-30.

0     

Rivera VM. Introduccion al Simposio Latino Americano. Rev Neurol. 2000;31(5):469.

29

Tejada-Simon MV, Zang YC, Yang D, Hong J, Li S, Singh RA, et al. Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis. Int Immunol. 2000;12(12):1641-50. PMID: 11099303.

59

Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J Immunol. 2000;164(8):4011-7. PMID: 10754292.

44

Zang YC, Hong J, Tejada-Simon MV, Li S, Rivera VM, Killian JM, et al. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis. Eur J Immunol. 2000;30(3):908-13. PMID: 10741408.

66

Zang YC, Samanta AK, Halder JB, Hong J, Tejada-Simon MV, Rivera VM, et al. Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5. Brain. 2000;123 ( Pt 9):1874-82. PMID: 10960051.

48

Zang YC, Yang D, Hong J, Tejada-Simon MV, Rivera VM, Zhang JZ. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS. Neurology. 2000;55(3):397-404. PMID: 10932275.

54

Hong J, Zang YC, Tejada-Simon MV, Kozovska M, Li S, Singh RA, et al. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol. 1999;163(6):3530-8. PMID: 10477628.

61

Kil K, Zang YC, Yang D, Markowski J, Fuoco GS, Vendetti GC, et al. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J Neuroimmunol. 1999;98(2):201-7. PMID: 10430053.

98

Kozovska ME, Hong J, Zang YC, Li S, Rivera VM, Killian JM, et al. Interferon beta induces T-helper 2 immune deviation in MS. Neurology. 1999;53(8):1692-7. PMID: 10563614.

28

Singh RA, Zang YC, Shrivastava A, Hong J, Wang GT, Li S, et al. Th1 and Th2 deviation of myelin-autoreactive T cells by altered peptide ligands is associated with reciprocal regulation of Lck, Fyn, and ZAP-70. J Immunol. 1999;163(12):6393-402. PMID: 10586029.

74

Zang YC, Kozovska MM, Hong J, Li S, Mann S, Killian JM, et al. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur J Immunol. 1999;29(5):1692-700. PMID: 10359124.

22

Kozovska M, Zang YC, Aebischer I, Lnu S, Rivera VM, Crowe PD, et al. T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: Structural requirements and clinical implications. Eur J Immunol. 1998;28(6):1894-901. PMID: 9645371.

14

Zang YC, Kozovska M, Aebischer I, Li S, Boehme S, Crowe P, et al. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis. Int Immunol. 1998;10(7):991-8. PMID: 9701037.

63

Jerger J, Alford B, Lew H, Rivera V, Chmiel R. Dichotic listening, event-related potentials, and interhemispheric transfer in the elderly. Ear Hear. 1995;16(5):482-98. PMID: 8654903.

0     

Trujillo JR, Garcia-Ramos G, Novak IS, Rivera VM, Huerta E, Essex M. Neurologic manifestations of AIDS: A comparative study of two populations from Mexico and the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(1):23-9. PMID: 8548343.

118

Safi HJ, Bartoli S, Hess KR, Shenaq SS, Viets JR, Butt GR, et al. Neurologic deficit in patients at high risk with thoracoabdominal aortic aneurysms: The role of cerebral spinal fluid drainage and distal aortic perfusion. J Vasc Surg. 1994;20(3):434-44; discussion 442-3. PMID: 8084037.

255

Crawford ES, Svensson LG, Hess KR, Shenaq SS, Coselli JS, Safi HJ, et al. A prospective randomized study of cerebrospinal fluid drainage to prevent paraplegia after high-risk surgery on the thoracoabdominal aorta. J Vasc Surg. 1991;13(1):36-45; discussion 45-6. PMID: 1987395.

85

Mawad ME, Rivera V, Crawford S, Ramirez A, Breitbach W. Spinal cord ischemia after resection of thoracoabdominal aortic aneurysms: MR findings in 24 patients. AJNR Am J Neuroradiol. 1990;11(5):987-91. PMID: 2121005.

44

Mawad ME, Rivera V, Crawford S, Ramirez A, Breitbach W. Spinal cord ischemia after resection of thoracoabdominal aortic aneurysms: MR findings in 24 patients. AJR Am J Roentgenol. 1990;155(6):1303-7. PMID: 2122684.

14

Rivera VM. Safety of intrathecal steroids in multiple sclerosis. Arch Neurol. 1989;46(7):718-9. PMID: 2535600.

0     

Olmos Garcia de Alba G, Gamboa Marrufo JD, Rengifo Ramos O, Calderon FE, Espinosa Tanguna R, Rivera Olmos VM, et al. Rett's syndrome with Lennox-Gastaut pattern. Clin Electroencephalogr. 1987;18(4):187-90. PMID: 3117441.

41

Jerger JF, Oliver TA, Chmiel RA, Rivera VM. Patterns of auditory abnormality in multiple sclerosis. Audiology. 1986;25(4-5):193-209. PMID: 3566629.

45

Rivera VM, Meyer JS, Hata T, Ishikawa Y, Imai A. Narcolepsy following cerebral hypoxic ischemia. Ann Neurol. 1986;19(5):505-8. PMID: 3717910.

3

Rivera VM. Multiple sclerosis. Is the mystery beginning to unfold? Postgrad Med. 1986;79(8):217-32. PMID: 3520524.

0     

Rivera VM. Stroke. A guide to differential diagnosis and prevention. Postgrad Med. 1985;77(4):81-8. PMID: 3975191.

51

Hannley M, Jerger JF, Rivera VM. Relationships among auditory brain stem responses, masking level differences and the acoustic reflex in multiple sclerosis. Audiology. 1983;22(1):20-33. PMID: 6830528.

5

Jerger J, Hannley M, Rivera V. Auditory brainstem response and the masking level difference. Ann N Y Acad Sci. 1982;388:466-70. PMID: 6953883.

5

Jerger J, Hannley M, Rivera V. Auditory brainstem response and the masking level difference. Ann N Y Acad Sci. 1982;388:466-70. PMID: 6953883.

6

Rivera VM. Intraspinal steroid therapy. Neurology. 1981;31(8):1060-1. PMID: 6894967.

15

Rivera VM, Grabois M, Deaton W, Breitbach W, Hines M. Modified snake venom in amyotrophic lateral sclerosis. Lack of clinical effectiveness. Arch Neurol. 1980;37(4):201-3. PMID: 7362484.

25

Jankovic J, Rivera VM. Hereditary myoclonus and progressive distal muscular atrophy. Ann Neurol. 1979;6(3):227-31. PMID: 534421.

5

Jankovic J, Rivera V. Hereditary myoclonus and progressive muscular atrophy: A new syndrome. Trans Am Neurol Assoc. 1978;103:116-8. PMID: 757033.

0     

Jankovic J, Rivera VM. Hereditary myoclonus and progressive spinal muscular atrophy: A new syndrome. Ann Neurol. 1978;4(2):170-1.

2

Perez FI, Hruska NA, Stell RL, Rivera VM. Computerized assessment of memory performance in dementia. Can J Neurol Sci. 1978;5(3):307-12. PMID: 359117.

0     

Rivera VM, Patten BM. Neuromyopathy in malignant hyperthermia. J Clin Psychiatry. 1978;39(1):67-71. PMID: 580262.

0     

Rivera VM. Acute hypokalemic myopathy in alcoholism. Arch Neurol. 1978;35(9):619. PMID: 687190.

0     

Guido EM, Rivera VM. Precordialgia as a manifestation of vertebrobasilar insufficiency. J Am Geriatr Soc. 1977;25(10):463-5. PMID: 903546.

0     

Rivera VM. Viruses and multiple sclerosis. Jama. 1977;238(12):1247. PMID: 578169.

0     

Rodriguez J, Rivera VM. Risk factors in stroke in a Mexican-American population (Houston). Neurol Neurocir Psiquiatr. 1977;18(2-3 Suppl):225-34. PMID: 616532.

1

Rivera VM. Letter: Symptomatic care of patients with amyotrophic lateral sclerosis. Jama. 1976;235(24):2584-5. PMID: 946858.

12

Perez FI, Gay JR, Taylor RL, Rivera VM. Patterns of memory performance in the neurologically impaired aged. Can J Neurol Sci. 1975;2(4):347-55. PMID: 1201525.

0     

Perez FI, Rivera VM, Meyer JS, Gay JR, Taylor RL, Mathew NT. Analysis of intellectual and cognitive performance in patients with multi-infarct dementia, vertebrobasilar insufficiency with dementia, and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1975;38(6):533-40. PMID: 1151420.

10

Rivera VM, Breitbach WB, Swanke L. Letter: Dantrolene in amyotrophic lateral sclerosis. Jama. 1975;233(8):863-4. PMID: 1173890.

9

Rivera VM, Keichian AH, Oliver RE. Persistent parkinsonism following neuroleptanalgesia. Anesthesiology. 1975;42(5):635-7. PMID: 1130732.

0     

Meyer JS, Bauer RB, Rivera-Olmos VM, Nolan DC, Lerner AM. Herpesvirus hominis encephalitis. Neurological manifestations and use of idoxuridine. Arch Neurol. 1970;23(5):438-50. PMID: 4319497.